Skip to content
Medical Health Aged Care, Mental Health

How We Think, Perceive, and Act Under the Microscope at Major UNSW Psychology Conference

The University of New South Wales < 1 min read

SYDNEY – [10/06/2025] – Nearly 400 researchers from a dozen countries are converging on UNSW Sydney from 17-20 June for a landmark joint meeting at the intersection of mind and brain sciences.

This gathering of minds will explore how people perceive, attend, think, learn, and act, aiming to advance scientific understanding while shedding light on urgent challenges across health, technology, policy, and society.

The conference will showcase cutting-edge research on topics ranging from AI and visual perception to decision-making about climate change, misinformation, and human development.

The event will feature significant keynote addresses from leading voices in their respective fields: Mac Shine from the University of Sydney will speak on how the human brain creates adaptive behaviours, Rachel Searston from the University of Adelaide will cover high-stakes decision-making, and Ben Newell from UNSW will address climate risk. Special sessions will explore real-world applications of psychological science, with workshops on educational psychology and behaviour in the workplace.

The program also offers a free, interactive public talk entitled "An Owner’s Guide to the Mind", exploring the science of memory, attention, and decision-making.  Journalists are welcome to attend selected sessions or arrange interviews with experts in psychology. A list of speakers and their topics is available on request.

For more information, please visit: https://conference.unsw.edu.au/en/epc-apcv-2025

Media Contact:  
Tom Melville  
0432 912 060  
[email protected]  


Contact details:

Media Contact:  
Tom Melville  
0432 912 060  
[email protected]  

More from this category

  • Medical Health Aged Care
  • 18/03/2026
  • 18:41
Samsung Bioepis Co., Ltd.

Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates

The agreement covers up to five assets, including SB36, a biosimilar candidate referencing Entyvio (vedolizumab), for collaboration of development and commercialization in global markets excluding China, Hong Kong, Taiwan, Macau, and Republic of KoreaSamsung Bioepis continues to pave the way for access to life-changing medicines by advancing a biosimilar pipeline across immunology and oncology   INCHEON, Korea--BUSINESS WIRE-- Samsung Bioepis Co., Ltd. announced today that the company has entered into a global license, development and commercialization agreement (DCA) with Sandoz for up to five biosimilar candidates under development by Samsung Bioepis, including SB36, a biosimilar candidate referencing Entyvio1 (vedolizumab). The…

  • Contains:
  • Medical Health Aged Care
  • 18/03/2026
  • 16:49
Palliative Care Australia

Better end-of-life care for older Australians must be the next step in aged care reform

Palliative Care Australia this week brought leaders from aged care, palliative care, health, advocacy, research and policy together in Melbourne for its inauguralPalliative Care…

  • Contains:
  • Mental Health, Property Real Estate
  • 18/03/2026
  • 12:02
Chapter One Advisors

National Property Company The Agency Group Strengthens People-First Growth Strategy with Reeboot AI Wellbeing Rollout

Highlights The Agency to provide all staff and agents and their families with complimentary access to Reeboot AI for a one-month period Initiative available…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.